The purpose of this study is to test whether ketamine and D-cycloserine can be safely and
effectively used for the treatment of depression. The investigators hypothesize that ketamine
will serve as a rapid acting and safe antidepressant in patients with bipolar depression, and
furthermore, that D-cycloserine will serve as an effective therapy following ketamine
treatment.